PicoCELA vs Impinj
PCLA and PI side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PCLA and PI compare
Impinj grew revenue faster over the last twelve months (7.7% versus −30.6% for PicoCELA).
Impinj keeps more of each dollar of sales as profit, with a net margin of −2.5% compared with −115% at PicoCELA.
Impinj scores higher on the StockData Score (6 against 1 for PicoCELA), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PCLA | PI |
|---|---|---|
| Size and price | ||
| Market cap | – | $5.2B |
| Share price | $6.00 | $168.54 |
| Change, 1 year | −36.3% | 10.1% |
| Change, 5 years | – | 106% |
| Beta (5Y) | 2.92 | 2.01 |
| Employees | 55 | 255 |
| StockData Score | ||
| Total score | 1 | 6 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 13.4× |
| P/B | – | 17.2× |
| EV/EBITDA | – | 414× |
| P/FCF | – | 79.3× |
| FCF yield | – | 1.3% |
| Fair value | – | $6.39 |
| Margin of safety | – | −2538% |
| Growth | ||
| Revenue growth (TTM) | −30.6% | 7.7% (better) |
| Revenue growth, 5Y average | – | 21.1% |
| Profitability | ||
| Gross margin | – | 53.5% |
| Operating margin | −110% | −0.71% (better) |
| Net margin | −115% | −2.5% (better) |
| FCF margin | −105% | 16.9% (better) |
| Return on equity | −225% | −3.8% (better) |
| Return on invested capital | −184% | −0.66% (better) |
| Financial health | ||
| Debt / equity | 0.69 | 0.62 (better) |
| Net debt / EBITDA | – | 5.76 |
| Interest coverage | – | −1.0× |
| Current ratio | 1.76 | 9.42 (better) |
| Altman Z-score | – | 13.00 |
| Piotroski F-score | 2 | 5 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | 0.01% | 106% |
| Held by insiders | – | 8.7% |
| Insider net buying, 12 months | – | −$169M |
| Superinvestors holding | – | 1 |
| Short interest, % of float | – | 8.3% |
Go deeper
- PCLA stock overview
- PCLA income statement
- PCLA valuation and score
- PI stock overview
- PI income statement
- PI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.